Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women’s Health Initiative Observational Study-Reference-Cited by-同舟云学术

Circulating estrogens and postmenopausal ovarian and endometrial cancer risk among current hormone users in the Women’s Health Initiative Observational Study

Published:2019-09-21 Issue:11 Volume:30 Page:1201-1211
ISSN:0957-5243
Container-title:Cancer Causes & Control
language:en
Short-container-title:Cancer Causes Control

Author:

Trabert Britton^ORCID,Coburn Sally B.,Falk Roni T.,Manson JoAnn E.,Brinton Louise A.,Gass Margery L.,Kuller Lewis H.,Rohan Thomas E.,Pfeiffer Ruth M.,Qi Lihong,Stefanick Marcia L.,Wentzensen Nicolas,Anderson Garnet L.,Xu Xia

Funder

National Institutes of Health

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10552-019-01233-8.pdf

Reference26 articles.

1. Trabert B et al (2012) Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study. Br J Cancer 107(7):1181–1187

2. Collaborative Group on Epidemiological Studies of Ovarian et al (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385(9980):1835–1842.